GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
2.960
+0.260 (9.59%)
At close: Sep 20, 2024, 3:55 PM
2.950
-0.010 (-0.34%)
After-hours: Sep 20, 2024, 4:00 PM EDT
GeoVax Labs Revenue
GeoVax Labs had revenue of $300.68K in the quarter ending June 30, 2024. This brings the company's revenue in the last twelve months to $300.68K.
Revenue (ttm)
$300.68K
Revenue Growth
n/a
P/S Ratio
18.90
Revenue / Employee
$17,687
Employees
17
Market Cap
24.82M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | 81.53K | -303.98K | -78.85% |
Dec 31, 2021 | 385.50K | -1.44M | -78.86% |
Dec 31, 2020 | 1.82M | 647.76K | 55.09% |
Dec 31, 2019 | 1.18M | 212.69K | 22.08% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Oncology Institute | 361.07M |
Pieris Pharmaceuticals | 20.87M |
VSee Health | 5.74M |
HCW Biologics | 3.92M |
OneMedNet | 1.02M |
Biora Therapeutics | 860.00K |
GOVX News
- 17 days ago - GeoVax to Participate in Upcoming Investor Conferences in September - GlobeNewsWire
- 22 days ago - GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market - GlobeNewsWire
- 4 weeks ago - GeoVax's stock slides 20% after company raises $8.5 million in stock sale - Market Watch
- 4 weeks ago - GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market - GlobeNewsWire
- 4 weeks ago - Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now - GlobeNewsWire
- 4 weeks ago - GeoVax's stock soars 54% to lead rally in companies developing mpox treatments - Market Watch
- 5 weeks ago - GeoVax to Present at the Emerging Growth Conference on August 21, 2024 - GlobeNewsWire
- 5 weeks ago - Mpox outbreak: 5 stocks to watch out for as the emergency unfolds - Invezz